Option Care Health, Inc. $OPCH Stock Holdings Lifted by Van Berkom & Associates Inc.

Key Points

• Van Berkom & Associates increased its Option Care Health stake by 18.2% in the third quarter, adding 397,369 shares to hold about 2.58 million shares worth $58.1 million.
• Option Care Health reported quarterly EPS of $0.49, matching estimates, while revenue of $1.49 billion topped forecasts and grew 4.1% year over year. Institutional investors collectively own 98.05% of the stock.
• Analysts’ consensus rating is Hold, with a consensus price target of $29.48; 14 analysts rated it Hold and two rated it Buy.

Van Berkom & Associates Inc. lifted its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 18.2% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,583,253 shares of the company's stock after buying an additional 397,369 shares during the quarter. Van Berkom & Associates Inc. owned approximately 1.72% of Option Care Health worth $58,097,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Dimensional Fund Advisors LP raised its position in Option Care Health by 0.9% during the first quarter. Dimensional Fund Advisors LP now owns 3,876,856 shares of the company's stock worth $104,368,000 after acquiring an additional 36,208 shares during the last quarter. Southpoint Capital Advisors LP grew its position in shares of Option Care Health by 20.0% in the first quarter. Southpoint Capital Advisors LP now owns 3,600,000 shares of the company's stock valued at $96,912,000 after purchasing an additional 600,000 shares during the last quarter. Bank of America Corp DE grew its position in shares of Option Care Health by 14.6% in the first quarter. Bank of America Corp DE now owns 1,945,015 shares of the company's stock valued at $52,360,000 after purchasing an additional 247,766 shares during the last quarter. The Manufacturers Life Insurance Company grew its position in shares of Option Care Health by 2.1% in the first quarter. The Manufacturers Life Insurance Company now owns 1,804,871 shares of the company's stock valued at $48,587,000 after purchasing an additional 36,906 shares during the last quarter. Finally, Jennison Associates LLC increased its stake in shares of Option Care Health by 4.2% during the 1st quarter. Jennison Associates LLC now owns 1,213,025 shares of the company's stock worth $32,655,000 after purchasing an additional 49,094 shares in the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Stock Performance

NASDAQ OPCH opened at $31.69 on Tuesday. The business's 50-day moving average price is $27.45 and its 200 day moving average price is $26.35. Option Care Health, Inc. has a twelve month low of $18.01 and a twelve month high of $36.80. The company has a market capitalization of $4.75 billion, a PE ratio of 22.80, a price-to-earnings-growth ratio of 1.92 and a beta of 0.47. The company has a current ratio of 1.54, a quick ratio of 0.98 and a debt-to-equity ratio of 0.87.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings results on Wednesday, November 4th. The company reported $0.49 EPS for the quarter, meeting the consensus estimate of $0.49. The company had revenue of $1.49 billion during the quarter, compared to analysts' expectations of $1.48 billion. Option Care Health had a return on equity of 19.06% and a net margin of 3.74%. The firm's revenue was up 4.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.45 EPS. On average, research analysts predict that Option Care Health, Inc. will post 1.70 earnings per share for the current year.

Wall Street Analyst Weigh In

OPCH has been the subject of several research reports. Morgan Stanley set a $32.05 price objective on Option Care Health in a research report on Monday, October 12th. William Blair cut Option Care Health from an "outperform" rating to a "market perform" rating in a report on Tuesday, October 6th. Truist Financial set a $32.05 target price on Option Care Health in a report on Wednesday, October 7th. Stephens downgraded Option Care Health from an "overweight" rating to an "equal weight" rating and dropped their price target for the stock from $30.00 to $24.00 in a research report on Friday, July 17th. Finally, JPMorgan Chase & Co. cut Option Care Health from an "overweight" rating to a "neutral" rating and set a $33.00 price target for the company. in a report on Wednesday, October 7th. Two equities research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $29.48.

About Option Care Health

Option Care Health, Inc is a U.S. provider of home and alternate-site infusion therapy services. The company coordinates infusion care for patients who need medications or nutritional support administered outside a hospital, including in their homes or at infusion centers.

Its services include specialty pharmacy, nursing, care coordination and clinical support. Option Care Health provides therapies for a range of acute and chronic conditions, including immune disorders, infections, bleeding disorders and nutritional needs.

The company serves patients and health care providers across the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.